Who is eligible To be eligible for transitional access, patients must either: be receiving private treatment with the cancer medicine at the time Pharmac begins its public funding; or start treatment ...

Starting from 1 July 2025, when a cancer medicine starts to be funded by Pharmac, patients in private facilities will be able to continue their treatment with publicly funded medicines in the same ...